Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunoprophylaxis with Simulect (basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units.
Rengel M, Fernández Rodriguez A, Gómez Huertas E, Plaza JJ, Ruiz San Millán JC, Oppenheimer F, Bustamante J, Checa D, Sanchez Plumed JA, García Pérez J, Sanz Guajardo A, Llorente S, Martin Govantes JA, Gentil MA, Gomez Ullate P, Sanchez Guisande D, Puig JM, Fernández C. Rengel M, et al. Among authors: gentil ma. Transplant Proc. 2003 Aug;35(5):1691-3. doi: 10.1016/s0041-1345(03)00575-x. Transplant Proc. 2003. PMID: 12962760
Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study.
González Molina M, Serón D, García del Moral R, Carrera M, Sola E, Gómez Ullate P, Capdevila L, Gentil MA; Spanish Mycophenolate Mofetil and Chronic Graft Nephropathy Study Group. González Molina M, et al. Among authors: gentil ma. Transplant Proc. 2002 Feb;34(1):335-7. doi: 10.1016/s0041-1345(01)02788-9. Transplant Proc. 2002. PMID: 11959313 Clinical Trial. No abstract available.
Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA. Gonzalez Molina M, et al. Among authors: gentil ma. Transplantation. 2004 Jan 27;77(2):215-20. doi: 10.1097/01.TP.0000100684.59784.FF. Transplantation. 2004. PMID: 14742984 Clinical Trial.
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM, Ekberg H, Mamelok RD, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Hernandez D, Kuypers DR, Brunet M. Grinyó JM, et al. Among authors: gentil ma. Nephrol Dial Transplant. 2009 Jul;24(7):2269-76. doi: 10.1093/ndt/gfp162. Epub 2009 Apr 8. Nephrol Dial Transplant. 2009. PMID: 19357111
Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study.
Lloberas N, Torras J, Cruzado JM, Andreu F, Oppenheimer F, Sánchez-Plumed J, Gentil MÁ, Brunet M, Ekberg H, Grinyó JM; Spanish Pharmacogenetic Symphony Substudy Group. Lloberas N, et al. Among authors: gentil ma. Nephrol Dial Transplant. 2011 Nov;26(11):3784-93. doi: 10.1093/ndt/gfr130. Epub 2011 Mar 22. Nephrol Dial Transplant. 2011. PMID: 21427078 Clinical Trial.
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
Llaudó I, Colom H, Giménez-Bonafé P, Torras J, Caldés A, Sarrias M, Cruzado JM, Oppenheimer F, Sánchez-Plumed J, Gentil MÁ, Ekberg H, Grinyó JM, Lloberas N. Llaudó I, et al. Among authors: gentil ma. Transpl Int. 2013 Feb;26(2):177-86. doi: 10.1111/tri.12018. Epub 2012 Dec 7. Transpl Int. 2013. PMID: 23216707 Free article.
89 results